Radically different
Open Letter to the European Council: Protecting ESF and ERDF: building on what works for people and regions Brussels, Belgium – 19 June 2026 Dear President Costa, dear Presidents, dear […]
The post Open Letter to the European Council: Protecting ESF and ERDF appeared first on Mental Health Europe.
NEWS RELEASE: ERIKS accelerates high-tech growth with launch of technology hub in the Netherlands ERIKS is strengthening its position in high-tech industries with the launch of a dedicated Technology Hub in Alkmaar, the Netherlands. By concentrating advanced OEM production, expanding specialised capabilities, and optimising its European supply chain, the company is accelerating growth in high-complexity…
The post ERIKS opens technology hub in Alkmaar for high-tech OEMs appeared first on Medical Design and Outsourcing.
We applaud the adoption of the Recommendation on respect of autonomy in mental healthcare by the Council of Europe on the 17th of June.
The post Joint statement: Council of Europe takes a positive step on autonomy in mental health care appeared first on Mental Health Europe.
Nature Neuroscience, Published online: 19 June 2026; doi:10.1038/s41593-026-02332-x
Cao et al. identify tryptamine as a sleep signal in mice. Wake-active monoaminergic neurons release tryptamine, which binds to GPR139 in POA neurons that suppress wake-promoting neurons. GPR139 agonists could be a new class of sleep medication.
Nature Neuroscience, Published online: 19 June 2026; doi:10.1038/s41593-026-02341-w
Erucamide, a fatty acid amide reduced in degenerating retinas, activates myeloid cells via TMEM19 to release neurotrophic and angiogenic factors, rescuing photoreceptors and vasculature in mouse models of retinal degeneration.
Nature Neuroscience, Published online: 19 June 2026; doi:10.1038/s41593-026-02339-4
Simultaneous voltage imaging of soma and dendrites in layer 2/3 cortical neurons in live mice reveals rich dynamics of spike back-propagation, with amplitude shaped by spiking history, dendrite location and behavioral state.
Nature Medicine, Published online: 19 June 2026; doi:10.1038/s41591-026-04519-y
Author Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial
Nature Biotechnology, Published online: 19 June 2026; doi:10.1038/s41587-026-03181-6
Retrotransposons are applied in plants for safe-harbor transgene integration.
Nature Biotechnology, Published online: 19 June 2026; doi:10.1038/s41587-026-03197-y
R2 retrotransposons are used to integrate DNA into plant and crop 25S ribosomal DNA sites.